NCT03030976
|
A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE) |
Unknown |
SLE |
CD19 CAR T-cells |
Mar-17 |
Mar-18 |
No results posted |
I |
NCT05030779
|
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus |
Recruiting |
SLE |
CD19/BCMA CAR T-cells |
Sep-21 |
Sep-22 |
Active |
I |
NCT05085418
|
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis |
Recruiting |
Immune Nephritis |
CD19/BCMA CAR T-cells |
Nov-21 |
Nov-24 |
Active |
I |
NCT04422912
|
Open-label Study to Determine the Maximum Tolerated Dose of DSG3-CAART in Mucosal-dominant PV Patients (mPV) |
Recruiting |
mPV |
DSG3-CAART |
Sep-20 |
Sep-26 |
Active |
I |
NCT05085431
|
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome |
Recruiting |
Syndrome |
CD19/BCMA CAR T-cells |
Nov-21 |
Nov-24 |
Active |
I |
NCT05085444
|
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma |
Recruiting |
Scleroderma |
CD19/BCMA CAR T-cells |
Oct-21 |
Oct-24 |
Active |
I |
NCT04561557
|
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Idiopathic Inflammatory Diseases of the Nervous System |
Recruiting |
Neuromyelitis Optica Spectrum Disorder |
BCMA CAR T-cells (CT103A) |
Sep-20 |
Dec-23 |
Active |
I |
NCT04146051
|
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) |
Recruiting |
Generalized MG |
BCMA CAR T-cells (Descartes-08) |
Dec-19 |
Dec-23 |
Active |
I/II |
NCT05263817
|
A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis |
Recruiting |
Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis |
CD19/BCMA CAR T cells |
Oct-21 |
Oct-24 |
Active |
I |
NCT05239702
|
Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases |
Recruiting |
Crohn’s Disease, Ulcerative Colitis, Dermatomyositis, Still's Disease, Autoimmune Diseases |
CD7 CAR T cells |
Feb-22 |
Dec-24 |
Active |
I |
NCT05451212
|
Open-label Study to Determine the Maximum Tolerated Dose of MuSK-CAART for MuSK Myasthenia Gravis |
Not yet recruiting |
MuSK MG |
MuSK-CAART |
Oct-22 |
Oct-28 |
Active |
I |